Company
Headquarters: Grafelfing, Germany
Employees: 67
CEO: Ms. Natalie Weigand
€263.8 Million
EUR as of July 1, 2024
US$283.3 Million
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
PharmaSGP Holding SE manufactures non-chemical, over-the-counter drugs, and other healthcare products. The company's pharmaceutical products include RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. It also offers products for the treatment of chronic indications, including pain and other age-related ailments. The company sells its products through pharmacies and wholesalers. It exports its products to European countries comprising Austria, Italy, Belgium, and Spain. PharmaSGP Holding SE was founded in 2012 and is based in Gräfelfing, Germany.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Prosegur Cia de Seguridad SA has the following listings and related stock indices.
Stock: FSX: PSG wb_incandescent
Stock: XETR: PSG wb_incandescent
Stock: BME: PSG wb_incandescent